Good Lifestyle

Management of our health can sometimes require more than simply eating the right food And exercise regularly. Whether it is to reach your office for allergies drugs or take a prescription medication to manage chronic disease, we often count on certain products for a little additional help. But sometimes, some of the same articles intended to make us feel better or to keep us healthy can be defective or dangerous due to production misadventures or other faults. And now, Food & Drug Administration (FDA) has published a handful of new warnings on medical products reminders. Read the rest to see if you are assigned by the latest agency alerts.

Read this then: 2.5 million pounds of meat recalled on contamination fears, USDA warns .

On March 28, the FDA announced that southern Dakota Jarman midwest cleaning systems , Inc., he had issued a voluntary recall for his 80% alcohol solution of topical disinfectant solution in hand The movement affects many of the two elements, which are marketed as a means of reducing bacteria on the skin between washing Hands with soap and water.

The affected products have been sold in transparent or white plastic bottles in large format, which may have been sold individually or in the event of four bottles. They can also be identified by their date of manufacture, which takes place from March 24 to December 18, 2020. A full list of NDC distributors and numbers affected items can be found in the opinion of the agency.

The company published the recall after the FDA tests discovered the presence of methanol in hand disinfectants. The agency warns that "substantial" exposure to chemicals can cause "nausea, vomiting, headache, blurred vision, coma, convulsions, permanent blindness, permanent damage to the central nervous system or to death". This is particularly dangerous for young children who accidentally ingest the product or adolescents and adults who drink it as alcohol.

Anyone with a disinfectant for the hands is advised to stop using it immediately and have articles "in accordance with local orders". Customers can also contact the company for a return, as well as with all questions or concerns. Anyone who believes he has experienced harmful health effects after using the products must immediately contact his health care provider.

Medicines were also reported in the recent series of warnings. On March 31, the FDA announced that New Jersey Camber Pharmaceuticals, Inc. Voluntarily recalled a lot of its oral suspension Atovaquone, 750 mg USP / 5 ml. The product was distributed nationally to wholesalers, distributors, retail pharmacies and correspondence pharmacies. AE0FCC31AE342FD3A1346EBB1F342FCB

The drug - which, according to the opinion, is generally prescribed for "prevention and treatment of pneumocystis jiroveci pneumonia (PCP) in adults and children 13 and over" who cannot tolerate other drugs - is packed in 210 ml plastic bottles. The affected products are stamped with the NDC 31722-629-21, UPC 331722629218 and the lot number E220182 with an expiration date of 12/2023.

The agency's opinion warns that the products may be contaminated by Bacillus cereus bacteria. For anyone who is immunocompromised, this means "there is a reasonable probability that microbial contamination of the oral suspension of the Atovaquone can cause scattered and potentially fatal infections such as endocarditis and infections with necrotic soft tissues".

The company advises anyone with the medication to stop using it. They must then throw it back or return it to its place of purchase and contact their doctor. Anyone with questions about the recall can reach the company by contacting the hotline or the e-mail address indicated in the agency's notice.

In relation: For more information, register for our daily newsletter .

The latest FDA warnings also include a medical device. The agency announced on April 3 that Abbott health care company Voluntarily recall the readers used for its free freestyle, free freestyle 14 days and its flash flash flashle glucose monitoring systems. The products are used to manage diabetes as well as a sensor brought to the back of the upper arm to collect glucose readings in real time.

The agency claims that the company has published the recall after receiving a "limited number of reports worldwide" from users for several years that the lithium-ion dough used in readers has inflated, overheated and "in very rare case, triggered or caught fire ". The company specifies that freestyle free sensors are not affected.

Depending on the notice, readers are not physically recalled. Customers can continue to use them until they charge the player's battery with the yellow USB cable and the adapter supplied with the product. "The USB cable supplied by Abbott limits the current to load the battery safely, while third -party components can allow much higher power, increasing the risk of fire," writes the company.

The company says that there has been no "unfavorable consequences for health" or deaths related to the issue and that "the risks are attenuated" if the readers are stored, loaded and used correctly. Customers with questions can contact the Abbott customer service hotline to the number indicated in the notice or learn more Dedicated company website .

The latest warnings issued by the FDA are not the only cases recently when medical products or medicines have been removed from the shelves due to safety problems. On March 22, the agency announced that LLC Laboratories Ascend had voluntarily recalled his dabigatran capsules, etc. More Minian medication .

This decision has occurred after the company discovered that the drug contained nitrosamine impurity - in particular the N -Nitrosodimethylamine - by rising above the acceptable daily contribution of the FDA (ADI). The opinion warned that even if people are regularly exposed to nitrosamines by water and food such as grilled meats, dairy and vegetables, exposure to higher quantities over time could increase the risk of cancer.

And on March 16, the U.S. Product Safety Commission (CPSC) announced that the pharmaceutical giant Pfizer Inc. had made a reminder for its Rimegeant medication Sold under the Nurtec ODT brand. In this case, the drug - prescribed to patients to migraine treatment - has been removed from the market because it was not sold in the child -resistant packaging required by law, creating a potentially serious risk of poisoning.